1 / 11

Commercialisation of alkaliphilic bacteria originating from Kenya

ABS Workshop on “certificate of origin/source/legal provenance”, Addis Ababa March 28 th -30 th 2007. Commercialisation of alkaliphilic bacteria originating from Kenya. Peter Munyi International Centre of Insect Physiology and Ecology (ICIPE) pmunyi@icipe.org.

jolie-williams
Download Presentation

Commercialisation of alkaliphilic bacteria originating from Kenya

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ABS Workshop on “certificate of origin/source/legal provenance”, Addis Ababa March 28th-30th 2007 Commercialisation of alkaliphilic bacteria originating from Kenya

  2. Peter Munyi International Centre of Insect Physiology and Ecology (ICIPE) pmunyi@icipe.org

  3. Name and type of genetic resource Alkaliphilic Bacterium (Extremophiles) -micro organisms that thrive under extreme conditions including high Ph and salt concentration and which live in the highly caustic lakes of Kenya’s Rift Valley so called ‘soda’ lakes.

  4. Actors involved • The Kenya Wildlife Service (KWS) (Kenya) • University of Leicester (UK) • Genencor International (USA) • Gist Brocades (the Netherlands)

  5. How the genetic resource is used • To manufacture a product, Indiage, that softens the fabric denim giving them the faded look. • To manufacture a product, Puradax, an ingredient in washing powders. Both products are believed to be enzymes maintained and multiplied through cloning. There is no known tk related to these products

  6. Genencor’s 2002 Annual Report

  7. Type/kind of ABS Agreement None

  8. Agreed benefits in the agreement • None as no agreement exists • However, the understanding is that ex post facto arrangements are under negotiation.

  9. Benefits realised to date • None, as no agreement exists. • However, the understanding is that these are under negotiations.

  10. Conclusions • Lack of clarity in Kenya’s legal framework has been cited as the cause of this case. • Lack of capacity and resources to address the issue in key Kenyan institutions. • Problems in regulating research in the academic sector. • Enforcement questions. • Issues arising due to pre and post CBD collections

  11. Questions and/or comments?? Thank you!!

More Related